Physician profile
John E Roberts
NPI 1386804797
$2,840.74
in general payments reported to CMS, 2019-2025
9 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $161 · 2021: $331 · 2022: $456 · 2023: $550 · 2024: $301 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,262.02 | 2019-2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $326.30 | 2019-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $311.07 | 2021-2025 | Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $282.72 | 2019-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Indivior INC. | $220.46 | 2021-2024 | Perseris |
| Janssen Pharmaceuticals, INC | $154.02 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $110.84 | 2019-2020 | |
| Bioxcel Therapeutics, INC. | $98.46 | 2023-2024 | Igalmi |
| Lundbeck LLC | $74.85 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.